| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Applications of process analytical technology to crystallization processes
|
Yu, Lawrence X
|
|
2004
|
56 |
3 |
p. 349-369
21 p.
|
artikel
|
| 2 |
A timely re-examination of drug polymorphism in pharmaceutical development and regulation
|
Grant, David J.W.
|
|
2004
|
56 |
3 |
p. 237-239
3 p.
|
artikel
|
| 3 |
Drug polymorphism and dosage form design: a practical perspective
|
Singhal, Dharmendra
|
|
2004
|
56 |
3 |
p. 335-347
13 p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
2004
|
56 |
3 |
p. ii-
1 p.
|
artikel
|
| 5 |
General principles of pharmaceutical solid polymorphism
|
Rodrı́guez-Spong, Barbara
|
|
2004
|
56 |
3 |
p. 241-274
34 p.
|
artikel
|
| 6 |
Guide to Authors
|
|
|
2004
|
56 |
3 |
p. 415-418
4 p.
|
artikel
|
| 7 |
High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids
|
Morissette, Sherry L.
|
|
2004
|
56 |
3 |
p. 275-300
26 p.
|
artikel
|
| 8 |
Impact of solid state properties on developability assessment of drug candidates
|
Huang, Lian-Feng
|
|
2004
|
56 |
3 |
p. 321-334
14 p.
|
artikel
|
| 9 |
Pharmaceutical solid polymorphism in drug development and regulation
|
Raw, Andre S.
|
|
2004
|
56 |
3 |
p. 235-236
2 p.
|
artikel
|
| 10 |
Phase transformation considerations during process development and manufacture of solid oral dosage forms
|
Zhang, Geoff G.Z
|
|
2004
|
56 |
3 |
p. 371-390
20 p.
|
artikel
|
| 11 |
Polymorphism in generic drug product development
|
Snider, Daniel A.
|
|
2004
|
56 |
3 |
p. 391-395
5 p.
|
artikel
|
| 12 |
Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs)
|
Raw, Andre S
|
|
2004
|
56 |
3 |
p. 397-414
18 p.
|
artikel
|
| 13 |
The computational prediction of pharmaceutical crystal structures and polymorphism
|
Price, Sarah L
|
|
2004
|
56 |
3 |
p. 301-319
19 p.
|
artikel
|
Tijdschrift beschrijving